AN2 Therapeutics, Inc. (ANTX) Net Income by Year
AN2 Therapeutics, Inc. reported a net loss of $35.2M in fiscal year 2025. This represents an increase of 31.5% from the prior fiscal year. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters AN2 Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ANTX Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
ANTX Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More AN2 Therapeutics, Inc. financials
Frequently Asked Questions
What was AN2 Therapeutics, Inc.'s net income in fiscal year 2025?
AN2 Therapeutics, Inc. reported a net loss of $35.2M in fiscal year 2025.
How fast is AN2 Therapeutics, Inc.'s net income growing?
AN2 Therapeutics, Inc. (ANTX) net income rose by 31.5% year over year, from -$51.3M to -$35.2M in fiscal year 2025.
How has AN2 Therapeutics, Inc.'s net income changed over the years?
Across the 5 fiscal years this page covers, AN2 Therapeutics, Inc. (ANTX) net income went from -$21.5M in fiscal year 2021 to -$35.2M in fiscal year 2025.
What was AN2 Therapeutics, Inc.'s net income in the most recent quarter?
AN2 Therapeutics, Inc. (ANTX) reported -$8.2M in net income in Q2 2026. This represents a decrease of 26.7% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what AN2 Therapeutics, Inc. (ANTX) reported on that line in every period on record.